Center for Applied Genomics

CHOP Research’s Distinguished Research Trainee Awards provide institution-wide recognition for exceptional CHOP Research trainees. The 2015 Awards sees two young researchers from the Center for Applied Genomics each claim the prestigious award.
Article by: Cornerstone (CHOP); June 05, 2015
 

In the largest genetic study to date of a challenging immunodeficiency disorder, CAG scientists have identified a gene that may be a "missing link" between overactive and underactive immune activity. The gene candidate also plays a key role in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and allergies.
Article by: Medical XPress; April 22, 2015
 

A new study from The Children’s Hospital of Philadelphia shows body mass index (BMI) during infancy may help to predict if a child will be obese by age four.
Article by: CHOP Cornerstone; March 24, 2015
 

Genomics researchers from the Center for Applied Genomics (CAG) at The Children’s Hospital of Philadelphia investigating a serious, rare disease called common variable immunodeficiency (CVID) have discovered a gene linked to immune defense.
Article by: CHOP Cornerstone; March 13, 2015
 

Scientists in Philadelphia have identified four new genes associated with the severe food allergy eosinophilic esophagitis (EoE). Because the genes appear to have roles in other allergic diseases and in inflammation, the findings may point toward potential new treatments for EoE.
Article by: Science Codex; November 21, 2014
 

Collaboration will bring together the premier pediatric genomics research organization, Center for Applied Genomics (CAG), with ex vivo gene therapy innovator, Medgenics.
Article by: GlobeNewswire; November 12, 2014
 

Scientists in Philadelphia have discovered a gene that dictates how much sleep we need, and say some of us are just programmed to need less sleep than others.
Article by: BBC; August 6, 2014
 

CHOP scientists have discovered a 'Thatcher gene' which allows people to survive on far less sleep than is recommended.
Article by: Daily Telegraph; August 6, 2014
 

Personalized medicine will be expensive in these early days of pioneering and planning. But individual genomic testing is not going to be exorbitant forever – and the ROI is gonna be big, both in patient outcomes and dollars saved."
Article by: OrthoSpine News; July 21, 2014
 

In the first genome-wide analysis of postsurgical pain in children, CAG researchers identified variations in genes that affect a child's need for pain-control drugs."
Article by: Medical XPress; June 30, 2014